COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1733: Articles 17321-17330  | Next

COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies
Garjani, A., Middleton, R. M., Hunter, R., Tuite-Dalton, K. A., Coles, A., Dobson, R., Duddy, M., Hughes, S., Pearson, O. R., Rog, D., Tallantyre, E. C., das Nair, R., Nicholas, R., Evangelou, N.
10.1101/2021.03.08.21253141 — Posted: 2021-03-10
A High Rate of COVID-19 Vaccine Hesitancy Among Arabs: Results of a Large-scale Survey
Qunaibi, E. A., Helmy, M., Basheti, I., Sultan, I.
10.1101/2021.03.09.21252764 — Posted: 2021-03-10 Discussion: Onsite
Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa
Jassat, W., Mudara, C., Ozougwu, L., Tempia, S., Blumberg, L., Davies, M.-A., Pillay, Y., Carter, T., Morewane, R., Wolmarans, M., von Gottberg, A., Bhiman, J. N., Walaza, S., Cohen, C.
10.1101/2021.03.09.21253184 — Posted: 2021-03-10
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics: A cross-sectional study
Hirschtick, J. L., Titus, A. R., Slocum, E., Power, L. E., Hirschtick, R. E., Elliott, M. R., McKane, P., Fleischer, N. L.
10.1101/2021.03.08.21252905 — Posted: 2021-03-10 Discussion: Onsite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Estcourt, L., Peto, L., Emberson, J. R., Staplin, N., Spata, E., Pessoa-Amorim, G., Campbell, M., Roddick, A., Brunskill, N. E., George, T., Zehnder, D., Tiberi, S., Aung, N. N., Uriel, A., Widdrington, J., Koshy, G., Brown, T., Scott, S., Baillie, J. K., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Roberts, D., Haynes, R., Landray, M. J.
10.1101/2021.03.09.21252736 — Posted: 2021-03-10 Discussion: Offsite
Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients
Kragstrup, T. W., Singh, H. S., Grundberg, I., Nielsen, A. L. L., Rivellese, F., Mehta, A., Goldberg, M. B., Filbin, M., Qvist, P., Bibby, B. M.
10.1101/2021.03.08.21252819 — Posted: 2021-03-10 Discussion: Onsite
Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection
Ioannou, G., O'Hare, A. M., Berry, K., Fan, V. S., Crothers, K., Eastment, M. C., Locke, E., Green, P., Shah, J. A., Dominitz, J.
10.1101/2021.03.08.21253090 — Posted: 2021-03-10
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
Greenbaum, U., Klein, K., Martinez, F., Song, J., Thall, P. F., Ramdial, J. L., Knape, C., Aung, F. M., Scroggins, J., Knopfelmacher, A., Mulanovich, V., Borjan, J., Adachi, J., Muthu, M., Leung, C., Correa Medina, M., Champlin, R., Olson, A., Alousi, A., Rezvani, K., Shpall, E. J.
10.1101/2021.03.08.21252775 — Posted: 2021-03-10
Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays
Santano, R., Barrios, D., Crispi, F., Crovetto, F., Vidal, M., Chi, J., Izquierdo, L., Gratacos, E., Moncunill, G., Dobano, C.
10.1101/2021.03.09.21252401 — Posted: 2021-03-10
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Becker, M., Dulovic, A., Junker, D., Ruetalo, N., Kaiser, P., Pinilla, Y., Heinzel, C., Haering, J., Traenkle, B., Wagner, T., Layer, M., Mehrlaender, M., Mirakaj, V., Held, J., Planatscher, H., Schenke-Layland, K., Krause, G., Strengert, M., Bakchoul, T., Althaus, K., Fendel, R., Kreidenweiss, A., Koeppen, M., Rothbauer, U., Schindler, M., Schneiderhan-Marra, N.
10.1101/2021.03.08.21252958 — Posted: 2021-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).